Conclusions: Chemotherapeutic drug sensitivity test was feasible and necessary for the patients of NSCLC and has its practical guidance for clinical individual chemotherapy.
结论：对非小细胞肺癌患者进行化疗药物敏感实验具有可行性和必要性，对于临床个体化化疗具有现实指导作用。
Methods: the drug sensitivity or resistance of 40 NSCLC samples to 9 chemotherapeutic drugs and combined chemotherapy were detected by MTT colorimetric assay, and compared the results.
方法：应用MTT显色分析法测定40例非小细胞肺癌实体瘤标本对9种化疗药物及其组成的联合化疗方案的敏感性或耐药性，并比较结果。
Results:Different cancer cells have different sensitivity to the same chemotherapeutic medicine and each tumor has its own drug-sensitivity table.
结果：不同肿瘤细胞对同一化疗药物的敏感性不同，不同肿瘤细胞有其各自的药敏谱。
Results:Different cancer cells have different sensitivity to the same chemotherapeutic medicine and each tumor has its own drug-sensitivity table.
结果：不同肿瘤细胞对同一化疗药物的敏感性不同，不同肿瘤细胞有其各自的药敏谱。
应用推荐